In vivo molecular pharmacology and antitumor activity of the targeted Akt inhibitor PX-316.
暂无分享,去创建一个
G. Powis | D. Mahadevan | E. Meuillet | A. Baker | L. Kirkpatrick | A. Coon | Jaime M. C. Gard | N. Ihle | Ryan R. Williams | B. George | Chelsea Stamper